Kartos Therapeutics
Tracked across 3 events · 20 articles · First seen Apr 20, 2026 · Last active Aug 21, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Kartos Therapeutics is being acquired by Ipsen for up to $1.75 billion, including an upfront payment and potential milestone payments. Its primary asset, navtemadlin, will be integrated into Ipsen's pipeline.
Apr 20, 2026 · 7 articles
Business
Impact: Kartos Therapeutics was acquired by Ipsen, providing shareholders with a $450 million upfront payment and potential milestones. The acquisition validates its lead asset navtemadlin.
Aug 21, 2026 · 7 articles
Business
Impact: Kartos Therapeutics is mentioned as a current board seat for Borellini; not directly affected by this event.
Jul 13, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Kartos Therapeutics live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard